22 Feb 2019
Tony Dickherber, SLAS Committee member, and Program Director at the National Cancer Institute (NCI), discusses emerging technologies in cancer diagnostics and monitoring, including high-speed, high-throughput, multiplex assays, and how they contribute to developing effective cancer treatments.
National Cancer Institute
Tony Dickherber is a Program Director of the National Cancer Institute’s (NCI) Center for Strategic Scientific Initiatives, and Director of the NCI Innovative Molecular Analysis Technologies program. The NCI Innovative Molecular Analysis Technologies program focuses exclusively on early stage technology development to address unmet needs in the cancer research arena.